跳至主要内容
临床试验/CTRI/2022/12/048283
CTRI/2022/12/048283招募中3 期

A multi-center randomized controlled trial to compare the efficacy, safety, and tolerability of high dose, short course Primaquine–A pilot study

ICMR National Institute of Malaria Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.P. vivax (asexual) malaria monoinfection confirmed by microscopy on a thin and thick blood smear
  • 2.Age 16 years and over of either gender.
  • 3.Fever > 37.5°C axillary, or a history of fever within 48 hours
  • 4.Female patients of child-bearing potential are included if they are non-lactating and willing to use contraceptive methods during the study period. Non-child bearing potential defined as:
  • 4.1 post-menopausal (12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH >40 mIU/mL), pre-menopausal and has had a hysterectomy or a bilateral oophorectomy (removal of the ovaries) or a bilateral tubal ligation with medical report verification or,
  • 4.2 Child-bearing potential, has a negative urine pregnancy test at screening, and agrees to comply with one of the following during the treatment stage of the study and for a period of 90 days after stopping study drug:
  • 4.2.1 Use of oral contraceptive, either combined or progesterone alone (if no contraindications to oral contraceptives exist).
  • 4.2.2 Barrier contraceptive if oral contraceptives are contraindicated
  • 4.2.3 Use of an intrauterine device.
  • 5.Willing to give informed consent.
  • 6.Willing to comply with protocol instructions and duration of follow up.
  • 7.Only patients living in and around the site facilities will be enrolled in the study to facilitate follow-up.

排除标准

  • 1.Patients with G6PD activity less than 30% of the adjusted male median (AMM), tested by UV spectrophotometry.
  • 2.Patients with mixed infection with P. vivax and P. falciparum (e.g. identified by Giemsa-stained smear or rapid diagnostic test).
  • 3.Patient with body weight less than 40 kg.
  • 4.Severe P. vivax malaria defined as per Indian National Guidelines criteria (Appendix I).
  • 5.Haemoglobin <8 g/dl to be measured by Hb auto analyser.
  • 6.Cannot tolerate oral treatment
  • 7.History of haemolytic anaemia or methemoglobinemia or blood transfusion within 90 days
  • 8.Pregnant and lactating females.
  • 9.Known allergy to chloroquine, primaquine or any other related drugs.
  • 10.Evidence of gastro-intestinal dysfunction that could alter absorption or motility (e.g., diarrhoea defined as >3 episodes of watery stools in the previous 24 h or patients who have had three episodes of vomiting within 24 h prior to screening).
  • 11.Use of concomitant medications that could induce haemolysis or haemolytic anaemia or depressants of myeloid element of the bone marrow.
  • 12.Any anti-malarial treatment taken 1 month prior to enrolment.
  • 13.Ongoing prophylaxis with drugs having anti-malarial activity
  • 14.Participation in any other investigational drug study of at least 3 months prior to screening
  • 15.Any other underlying disease that could compromise the diagnosis and the evaluation of the response to the study medication (including clinical symptoms of immunosuppression, HIV, Hepatitis, tuberculosis, Splenectomy conducted earlier as confirmed by history or clinical examination; evidence of clinically significant cardiovascular, pulmonary, metabolic, gastrointestinal, neurological, or endocrine diseases, malignancy, or other abnormalities.
  • 16.Retinal/visual field defects or auditory defects and history of psoriasis and porphyria.

研究者

发起方
ICMR National Institute of Malaria Research

相似试验

已完成
不适用
Autoinflation for Aboriginal and Torres Strait Islander Children with OME (middle ear infection)Health of Aboriginal ChildrenEar - Other ear disordersInfection - Other infectious diseasesOtitis Media with Effusion
ACTRN12617001652369Western Sydney University150
已完成
3 期
A multicentre randomised controlled trial to compare the efficacy of ex-vivo oxygenated hypothermic machine perfusion with non-oxygenated hypothermic machine perfusion of kidneys from donors older than 50 years of age and donated after circulatory death.Endstage renal failure1002914910038365Renal insufficiency
NL-OMON44723niversity of Oxford93
已完成
不适用
A proactive and structured telephone based intervention to reduce carer burden and depression among carers of cancer patientsCarer burdenDepression/anxietyQuality of lifeUnmet needsHealth literacyCancer - Any cancerMental Health - DepressionMental Health - Anxiety
ACTRN12613000731796Deakin University230
招募中
不适用
A multicentre randomized controlled trial to improve the AccUracy of Referrals to the emerGency departmEnt of patieNts with chesT pain by using the modified HEART score in Emergency Medical Transport(URGENT 2.0)acute coronary syndrome
NL-OMON55210Viecuri Medisch Centrum voor Noord-Limburg852
招募中
不适用
A multicenter randomized controlled trial to evaluate overall morbidity after total minimally invasive esophagectomy versus hybrid esophagectomyC15.9Oesophagus, unspecified
DRKS00027927Klinik für Allgemeine, Viszeral- und Transplantationschirurgie Universitätsklinikum Tübingen152